GENEWATCH UKActive
Key figures
Ratios
2025/26Balance sheet structure
Filed accounts2019/20–2025/26
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | 20,167 |
| Cash at bank and in hand | 233,118 | 163,544 | 112,360 | 85,195 | 76,624 |
| Total assets | 233,572 | 164,001 | 114,179 | 85,994 | 77,427 |
| Total liabilities | 226,420 | 156,849 | 107,027 | 78,842 | 70,275 |
| Net assets / total equity | 7,152 | 7,152 | 7,152 | 7,152 | 7,152 |
| Average number of employees | 2 | 3 | 3 | 3 | 2 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2026The principal activity of the company is to preserve and protect the social, environmental, human rights, animal and human health and welfare of the inhabitants of the world through the promotion of ethical, social, human health, environmental, human rights and animal welfare considerations in decision making about genetic engineering and other genetic technologies.
As described in the company's latest filed accounts.
Summary: GENEWATCH UK
Company
GENEWATCH UK is a private company limited by guarantee registered with Companies House under company number 03556885. It was incorporated on 1 May 1998. Its status is active. The registered office is in Manchester (M4). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2025/26 (period ending 31 May 2026); the company files small company accounts (filleted). Turnover was £20,167. Net assets were £7,152, up 0% on the previous year. Cash at bank and in hand was £76,624. Total assets were £77,427 and total liabilities £70,275. The company had an average of 2 employees. Figures are available for 7 financial years (2019/20–2025/26).
Filing deadlines
The next accounts are due by 29 Feb 2028. The next confirmation statement is due by 21 May 2027.